chr1-74041242-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001105659.2(LRRIQ3):c.1689G>T(p.Lys563Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000163 in 1,585,446 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001105659.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LRRIQ3 | NM_001105659.2 | c.1689G>T | p.Lys563Asn | missense_variant | 7/8 | ENST00000354431.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LRRIQ3 | ENST00000354431.9 | c.1689G>T | p.Lys563Asn | missense_variant | 7/8 | 5 | NM_001105659.2 | P2 | |
LRRIQ3 | ENST00000395089.5 | c.1689G>T | p.Lys563Asn | missense_variant | 6/7 | 5 | P2 | ||
LRRIQ3 | ENST00000417067.5 | c.131-14273G>T | intron_variant | 2 | |||||
LRRIQ3 | ENST00000415760.5 | c.*2703+449G>T | intron_variant, NMD_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 151920Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000192 AC: 44AN: 228596Hom.: 0 AF XY: 0.000202 AC XY: 25AN XY: 123988
GnomAD4 exome AF: 0.000170 AC: 243AN: 1433408Hom.: 1 Cov.: 30 AF XY: 0.000178 AC XY: 127AN XY: 712124
GnomAD4 genome AF: 0.000105 AC: 16AN: 152038Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 12, 2021 | The c.1689G>T (p.K563N) alteration is located in exon 7 (coding exon 6) of the LRRIQ3 gene. This alteration results from a G to T substitution at nucleotide position 1689, causing the lysine (K) at amino acid position 563 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at